Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal ...

A study identifies beta-synuclein in blood as a potential early biomarker for Alzheimer’s disease. This protein’s levels rise ...

When the researchers inhibited EZH2 in precursor cell development, the neurons had more action potentials, synapse markers, and maturation RNA expression compared to nontreated cells. Because EZH2 ...